Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015

Detalhes bibliográficos
Autor(a) principal: Nero, Nicola Aliceen
Data de Publicação: 2023
Tipo de documento: Tese
Idioma: eng
Título da fonte: Biblioteca Digital de Teses e Dissertações da USP
Texto Completo: https://www.teses.usp.br/teses/disponiveis/22/22132/tde-16052023-092813/
Resumo: Human immunodeficiency virus (HIV) is an infection that affects the body\'s immune system, specifically the white blood cells called CD4 count (WHO, 2022). As a global health concern, HIV/AIDS has been around for decades and to date, there is no known cure for the disease, however, with good health seeking behavirous, treatment, care and support, many persons affected are continuing to live long, comfortable and adoptable lives. Objective: The main objective of this study was to analyze the survival of people living with HIV and AIDS in Guyana from 2003 to 2015. Method: A retrospective cohort study was done of individuals with HIV/AIDS, notified and in care at seventeen (17) HIV Care and Treatment Sites, Ministry of Health, Guyana, from 2003 to 2015. The study took the form of a desk review of a cohort of individuals entered in the registry, consisting of clinical and treatment information that assisted to answer the proposed questions. Result: Of the 17 HIV Care and Treatment Sites assessed, the final bank produced a total of 1,067 (one thousand and sixty-seven patients) for analysis. Fifty six (56%) female and forty four 44% male. Eight variables were evaluated for this study that provided specific results as per analysis. Conclusion: Overall, patients with a high category of the CD4 variable have less risk of death and a good overall survival state and co-morbidities do contribute to an early death, especially if the ARV treatment regimen is not adhered to. Guyana\'s priority purposes are to reduce the transmission of HIV and improve the quality of life of persons living with HIV/AIDS. With great efforts and collaboration, several strategies are combined to improve access to adequate and high quality treatment care and support to all persons living with HIV/AIDS.
id USP_061a37d10f75a6c39821bf1dd80391ef
oai_identifier_str oai:teses.usp.br:tde-16052023-092813
network_acronym_str USP
network_name_str Biblioteca Digital de Teses e Dissertações da USP
repository_id_str 2721
spelling Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015Tempo de sobrevivência de pessoas vivendo com HIV/AIDS na Guiana de 2003 a 2015AIDSAIDSAnti-retroviralAntirretroviraisHIV testingSobrevivênciaSurvivalTeste de HIVVariablesVariáveisHuman immunodeficiency virus (HIV) is an infection that affects the body\'s immune system, specifically the white blood cells called CD4 count (WHO, 2022). As a global health concern, HIV/AIDS has been around for decades and to date, there is no known cure for the disease, however, with good health seeking behavirous, treatment, care and support, many persons affected are continuing to live long, comfortable and adoptable lives. Objective: The main objective of this study was to analyze the survival of people living with HIV and AIDS in Guyana from 2003 to 2015. Method: A retrospective cohort study was done of individuals with HIV/AIDS, notified and in care at seventeen (17) HIV Care and Treatment Sites, Ministry of Health, Guyana, from 2003 to 2015. The study took the form of a desk review of a cohort of individuals entered in the registry, consisting of clinical and treatment information that assisted to answer the proposed questions. Result: Of the 17 HIV Care and Treatment Sites assessed, the final bank produced a total of 1,067 (one thousand and sixty-seven patients) for analysis. Fifty six (56%) female and forty four 44% male. Eight variables were evaluated for this study that provided specific results as per analysis. Conclusion: Overall, patients with a high category of the CD4 variable have less risk of death and a good overall survival state and co-morbidities do contribute to an early death, especially if the ARV treatment regimen is not adhered to. Guyana\'s priority purposes are to reduce the transmission of HIV and improve the quality of life of persons living with HIV/AIDS. With great efforts and collaboration, several strategies are combined to improve access to adequate and high quality treatment care and support to all persons living with HIV/AIDS.O vírus da imunodeficiência humana (HIV) é uma infecção que afeta o sistema imunológico do corpo, especificamente os glóbulos brancos chamados contagem de CD4 (OMS, 2022). Como uma preocupação de saúde global, o HIV/AIDS existe há décadas e, até o momento, não há cura conhecida para a doença; vidas confortáveis e adotáveis. Objetivo: O objetivo principal deste estudo foi analisar a sobrevivência de pessoas vivendo com HIV e AIDS na Guiana de 2003 a 2015. Método: Foi feito um estudo de coorte retrospectivo de indivíduos com HIV/AIDS, notificados e atendidos aos dezessete (17 ) Locais de Cuidados e Tratamento de HIV, Ministério da Saúde, Guiana, de 2003 a 2015. O estudo assumiu a forma de uma revisão documental de uma coorte de indivíduos inseridos no registro, consistindo em informações clínicas e de tratamento que ajudaram a responder às perguntas propostas . Resultado: Dos 17 Centros de Atendimento e Tratamento do HIV avaliados, o banco final produziu um total de 1.067 (mil e sessenta e sete pacientes) para análise. Cinquenta e seis (56%) mulheres e quarenta e quatro 44% homens. Oito variáveis foram avaliadas para este estudo que forneceram resultados específicos conforme análise. Conclusão: No geral, os pacientes com alta categoria da variável CD4 têm menos risco de morte e um bom estado geral de sobrevida e comorbidades contribuem para uma morte precoce, especialmente se o regime de tratamento ARV não for aderido. Os propósitos prioritários da Guiana são reduzir a transmissão do HIV e melhorar a qualidade de vida das pessoas que vivem com HIV/AIDS. Com grande esforço e colaboração, várias estratégias são combinadas para melhorar o acesso ao tratamento adequado e de alta qualidade e apoio a todas as pessoas vivendo com HIV/AIDS.Biblioteca Digitais de Teses e Dissertações da USPGir, ElucirNero, Nicola Aliceen2023-01-20info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttps://www.teses.usp.br/teses/disponiveis/22/22132/tde-16052023-092813/reponame:Biblioteca Digital de Teses e Dissertações da USPinstname:Universidade de São Paulo (USP)instacron:USPLiberar o conteúdo para acesso público.info:eu-repo/semantics/openAccesseng2023-05-25T18:20:48Zoai:teses.usp.br:tde-16052023-092813Biblioteca Digital de Teses e Dissertaçõeshttp://www.teses.usp.br/PUBhttp://www.teses.usp.br/cgi-bin/mtd2br.plvirginia@if.usp.br|| atendimento@aguia.usp.br||virginia@if.usp.bropendoar:27212023-05-25T18:20:48Biblioteca Digital de Teses e Dissertações da USP - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
Tempo de sobrevivência de pessoas vivendo com HIV/AIDS na Guiana de 2003 a 2015
title Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
spellingShingle Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
Nero, Nicola Aliceen
AIDS
AIDS
Anti-retroviral
Antirretrovirais
HIV testing
Sobrevivência
Survival
Teste de HIV
Variables
Variáveis
title_short Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
title_full Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
title_fullStr Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
title_full_unstemmed Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
title_sort Length of survival of people living with HIV/AIDS in Guyana from 2003 to 2015
author Nero, Nicola Aliceen
author_facet Nero, Nicola Aliceen
author_role author
dc.contributor.none.fl_str_mv Gir, Elucir
dc.contributor.author.fl_str_mv Nero, Nicola Aliceen
dc.subject.por.fl_str_mv AIDS
AIDS
Anti-retroviral
Antirretrovirais
HIV testing
Sobrevivência
Survival
Teste de HIV
Variables
Variáveis
topic AIDS
AIDS
Anti-retroviral
Antirretrovirais
HIV testing
Sobrevivência
Survival
Teste de HIV
Variables
Variáveis
description Human immunodeficiency virus (HIV) is an infection that affects the body\'s immune system, specifically the white blood cells called CD4 count (WHO, 2022). As a global health concern, HIV/AIDS has been around for decades and to date, there is no known cure for the disease, however, with good health seeking behavirous, treatment, care and support, many persons affected are continuing to live long, comfortable and adoptable lives. Objective: The main objective of this study was to analyze the survival of people living with HIV and AIDS in Guyana from 2003 to 2015. Method: A retrospective cohort study was done of individuals with HIV/AIDS, notified and in care at seventeen (17) HIV Care and Treatment Sites, Ministry of Health, Guyana, from 2003 to 2015. The study took the form of a desk review of a cohort of individuals entered in the registry, consisting of clinical and treatment information that assisted to answer the proposed questions. Result: Of the 17 HIV Care and Treatment Sites assessed, the final bank produced a total of 1,067 (one thousand and sixty-seven patients) for analysis. Fifty six (56%) female and forty four 44% male. Eight variables were evaluated for this study that provided specific results as per analysis. Conclusion: Overall, patients with a high category of the CD4 variable have less risk of death and a good overall survival state and co-morbidities do contribute to an early death, especially if the ARV treatment regimen is not adhered to. Guyana\'s priority purposes are to reduce the transmission of HIV and improve the quality of life of persons living with HIV/AIDS. With great efforts and collaboration, several strategies are combined to improve access to adequate and high quality treatment care and support to all persons living with HIV/AIDS.
publishDate 2023
dc.date.none.fl_str_mv 2023-01-20
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.teses.usp.br/teses/disponiveis/22/22132/tde-16052023-092813/
url https://www.teses.usp.br/teses/disponiveis/22/22132/tde-16052023-092813/
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv
dc.rights.driver.fl_str_mv Liberar o conteúdo para acesso público.
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Liberar o conteúdo para acesso público.
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.coverage.none.fl_str_mv
dc.publisher.none.fl_str_mv Biblioteca Digitais de Teses e Dissertações da USP
publisher.none.fl_str_mv Biblioteca Digitais de Teses e Dissertações da USP
dc.source.none.fl_str_mv
reponame:Biblioteca Digital de Teses e Dissertações da USP
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Biblioteca Digital de Teses e Dissertações da USP
collection Biblioteca Digital de Teses e Dissertações da USP
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da USP - Universidade de São Paulo (USP)
repository.mail.fl_str_mv virginia@if.usp.br|| atendimento@aguia.usp.br||virginia@if.usp.br
_version_ 1815257070562181120